Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 13, 2014 - Issue 10
Submit an article Journal homepage
336
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Characteristics associated with drug-induced liver injury from interferon beta in multiple sclerosis patients

Kaarina KowalecUniversity of British Columbia (UBC), Neuroscience Program, Room S178, 2211 Wesbrook Mall, Vancouver, British Columbia V6T 2B5, Canada+1 604 822 0759; [email protected];Child & Family Research Institute, Vancouver, Canada;BC Children’s Hospital, Pharmaceutical Outcomes Programme, Vancouver, Canada
, MSc,
Elaine KingwellUniversity of British Columbia, Division of Neurology, Faculty of Medicine, Vancouver, Canada
, PhD,
Eric M YoshidaUniversity of British Columbia, Division of Gastroenterology, Faculty of Medicine, Vancouver, Canada
, MD,
Ruth Ann MarrieUniversity of Manitoba, Department of Internal Medicine, Winnipeg, Canada;University of Manitoba, Department of Community Health Sciences, Winnipeg, Canada
, MD PhD,
Marcelo KremenchutzkyWestern University, Department of Clinical Neurological Sciences, London, Canada
, MD,
Trudy L CampbellDalhousie University, Halifax, Canada
, NP,
Mia WadeliusUppsala University Hospital, Uppsala, Sweden
, MD PhD,
Bruce CarletonChild & Family Research Institute, Vancouver, Canada;BC Children’s Hospital, Pharmaceutical Outcomes Programme, Vancouver, Canada;University of British Columbia, Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, Vancouver, Canada
, PharmD &
Helen TremlettUniversity of British Columbia (UBC), Neuroscience Program, Room S178, 2211 Wesbrook Mall, Vancouver, British Columbia V6T 2B5, Canada+1 604 822 0759; [email protected];University of British Columbia, Division of Neurology, Faculty of Medicine, Vancouver, Canada
, PhD show all
Pages 1305-1317 | Published online: 18 Aug 2014

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Dejan Jakimovski, Caila B Vaughn, Svetlana Eckert, Robert Zivadinov & Bianca Weinstock-Guttman. (2020) Long-term drug treatment in multiple sclerosis: safety success and concerns. Expert Opinion on Drug Safety 19:9, pages 1121-1142.
Read now

Articles from other publishers (7)

Zuber Khan, Ghanshyam Das Gupta & Sidharth Mehan. (2023) Cellular and Molecular Evidence of Multiple Sclerosis Diagnosis and Treatment Challenges. Journal of Clinical Medicine 12:13, pages 4274.
Crossref
Massimiliano Mirabella, Pietro Annovazzi, Wallace Brownlee, Jeffrey A. Cohen, Christoph Kleinschnitz & Christian Wolf. (2022) Treatment Challenges in Multiple Sclerosis – A Continued Role for Glatiramer Acetate?. Frontiers in Neurology 13.
Crossref
Marco Biolato, Assunta Bianco, Matteo Lucchini, Antonio Gasbarrini, Massimiliano Mirabella & Antonio Grieco. (2021) The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative Review. CNS Drugs 35:8, pages 861-880.
Crossref
Hans L. Tillmann & Don C. Rockey. (2020) Signatures in drug-induced liver injury. Current Opinion in Gastroenterology 36:3, pages 199-205.
Crossref
Hans L. Tillmann, Huiman X. Barnhart, Jose Serrano & Don C. Rockey. (2018) Novel Approaches to Causality Adjudication in Drug-Induced Liver Disease. Current Hepatology Reports 17:3, pages 276-282.
Crossref
Kaarina Kowalec, Galen E. B. Wright, Britt I. Drögemöller, Folefac Aminkeng, Amit P. Bhavsar, Elaine Kingwell, Eric M. Yoshida, Anthony Traboulsee, Ruth Ann Marrie, Marcelo Kremenchutzky, Trudy L. Campbell, Pierre Duquette, Naga Chalasani, Mia Wadelius, Pär Hallberg, Zongqi Xia, Philip L. De Jager, Joshua C. Denny, Mary F. Davis, Colin J. D. Ross, Helen Tremlett & Bruce C. Carleton. (2018) Common variation near IRF6 is associated with IFN-β-induced liver injury in multiple sclerosis. Nature Genetics 50:8, pages 1081-1085.
Crossref
. (2015) Interferon-β-1a/interferon-β-1b. Reactions Weekly 1569:1, pages 135-135.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.